The characteristics and outcomes of patients with multiple myeloma dual refractory or intolerant to bortezomib and lenalidomide in the era of carfilzomib and pomalidomide
在卡非佐米和泊马度胺时代，对硼替佐米和来那度胺双重耐药或不耐受的多发性骨髓瘤患者的特征和预后
期刊:Leukemia & Lymphoma
影响因子:2.2
doi:10.3109/10428194.2013.803547
Wang, Tzu-Fei; Ahluwalia, Rohan; Fiala, Mark A; Trinkaus, Kathryn M; Cox, Doug P; Jaenicke, Matthew; Moliske, Caitlin C; Carson, Kenneth R; Wildes, Tanya M; Tomasson, Michael H; Stockerl-Goldstein, Keith E; Vij, Ravi
